Significance of Furin Expression in Thyroid Neoplastic Transformation

Angiotensin-Converting Enzyme 2 (ACE2), Transmembrane Serine Protease 2 (TMPRSS2), and Furin were known to be key players in the SARS-CoV-2 infection, and the thyroid gland was revealed to be one of the relevant targets of the virus. Regardless of the viral infection, the expression of these molecules in the thyroid gland and their putative role in the neoplastic transformation of the thyrocytes has not been thoroughly explored. In this work, we aimed to characterize the mRNA and protein expression pattern of ACE2, TMPRSS2, and Furin in a series of patients with thyroid lesions. Our main results revealed a significantly decreased expression of ACE2 mRNA in the thyroid neoplasms in comparison to normal adjacent tissue. Furin mRNA was significantly increased in thyroid neoplasms when compared to normal adjacent tissue. In addition, a higher Furin mRNA level in thyroid carcinomas was associated with the presence of lymph node metastasis. Furin mRNA expression revealed a high discriminatory power between adjacent tissue and neoplasms. Protein expression of these molecules did not correlate with mRNA expression. Our study shows the mRNA downregulation of ACE2 and overexpression of Furin in thyroid neoplasms. Further studies are required to clarify if Furin expression can be a potential diagnostic indicator in thyroid neoplasia.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:15

Enthalten in:

Cancers - 15(2023), 15 vom: 01. Aug.

Sprache:

Englisch

Beteiligte Personen:

Azevedo, Maria Teresa [VerfasserIn]
Macedo, Sofia [VerfasserIn]
Canberk, Sule [VerfasserIn]
Cardoso, Luís [VerfasserIn]
Gaspar, Tiago Bordeira [VerfasserIn]
Pestana, Ana [VerfasserIn]
Batista, Rui [VerfasserIn]
Sobrinho-Simões, Manuel [VerfasserIn]
Soares, Paula [VerfasserIn]

Links:

Volltext

Themen:

ACE2
Furin
Journal Article
TMPRSS2
Thyroid
Thyroid neoplasms

Anmerkungen:

Date Revised 14.08.2023

published: Electronic

Citation Status Publisher

doi:

10.3390/cancers15153909

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM360682308